12:00 AM
Nov 11, 2013
 |  BC Week In Review  |  Clinical News  |  Regulatory

Embeda morphine/naltrexone regulatory update

Pfizer said FDA approved an update to the manufacturing process of Embeda morphine/naltrexone for managing pain. The process addresses the stability issue that led to the drug's...

Read the full 112 word article

User Sign in

Trial Subscription

Get a 4-week free trial subscription to BioCentury Week In Review

Article Purchase

$35 USD
More Info >